Skip to main navigation Skip to search Skip to main content

Mortality After the First Diagnosis of Schizophrenia-Spectrum Disorders: A Population-based Retrospective Cohort Study

  • Paul Kurdyak*
  • , Emilie Mallia
  • , Claire de Oliveira
  • , Andre F Carvalho
  • , Nicole Kozloff
  • , Juveria Zaheer
  • , Wanda M Tempelaar
  • , Kelly K Anderson
  • , Christoph U Correll
  • , Aristotle N Voineskos
  • *Corresponding author for this work
  • Centre for Addiction and Mental Health (Toronto)
  • Institute for Clinical Evaluative Sciences
  • Zucker Hillside Hospital

Research output: Contribution to journal › Article › Academic › peer-review

28 Citations (Scopus)

Abstract

There is emerging evidence of high mortality rates after the first diagnosis of psychotic disorder. The objective of this study was to estimate the standardized mortality ratio (SMR) in a population-based cohort of individuals with a first diagnosis of schizophrenia-spectrum psychotic disorder (SSD). The cohort included a population-based sample of individuals with a first diagnosis of SSD based on the first diagnosis occurring during hospitalization or in an outpatient setting between 2007 and 2010 in Ontario, Canada. All patients were followed for 5 years after the first diagnosis. The primary outcome was SMR, including all-cause, suicide-related, accidental, and other causes. Between 2007 and 2010, there were 2382 patients in the hospitalization cohort and 11 003 patients in the outpatient cohort. Over the 5-year observation period, 97 (4.1%) of the hospitalization cohort and 292 (2.7%) of the outpatient cohort died, resulting in an SMR of 13.6 and 9.1, respectively. In both cohorts, suicide was the most common cause of death. Approximately 1 in 25 patients with a first diagnosis of SSD during hospitalization, and 1 in 40 patients with a first diagnosis of SSD in an outpatient setting, died within 5 years of first diagnosis in Ontario, Canada. This mortality rate is between 9 and 13 times higher than would be expected in the age-matched general population. Based on these data, timely access to services should be a public health priority to reduce mortality following a first diagnosis of an SSD.

Original languageEnglish
Pages (from-to)864-874
Number of pages11
JournalSchizophrenia Bulletin
Volume47
Issue number3
DOIs
Publication statusPublished - May 2021
Externally publishedYes

Bibliographical note

© The Author(s) 2021. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: [email protected].

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Mortality After the First Diagnosis of Schizophrenia-Spectrum Disorders: A Population-based Retrospective Cohort Study'. Together they form a unique fingerprint.

Cite this